Emergent BioSolutions (EBS) Income from Non-Controlling Interests (2011 - 2013)

Emergent BioSolutions' Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at -$5000.0 for Q4 2013.

• On a quarterly basis, Income from Non-Controlling Interests rose 99.55% year-over-year to -$5000.0 in Q4 2013; TTM through Sep 2014 was -$5000.0, a 99.75% increase from a year earlier, with the FY2013 full-year figure at -$876000.0, up 83.72% from the prior year.
• Income from Non-Controlling Interests climbed to -$5000.0 in Q4 2013 per EBS's latest filing, from -$128000.0 in the prior quarter.
• Across five years, Income from Non-Controlling Interests topped out at -$5000.0 in Q4 2013 and bottomed at -$2.1 million in Q2 2012.
• The 3-year median for Income from Non-Controlling Interests is -$1.1 million (2012), against an average of -$1.1 million.
• Across the five-year window, Income from Non-Controlling Interests slipped 23.65% in 2012 and jumped 99.55% in 2013, its largest moves.
• Year by year, Income from Non-Controlling Interests stood at -$1.8 million in 2011, then soared by 37.11% to -$1.1 million in 2012, then soared by 99.55% to -$5000.0 in 2013.
• Per Business Quant, the three latest EBS Income from Non-Controlling Interests figures stand at -$5000.0 (Q4 2013), -$128000.0 (Q2 2013), and -$743000.0 (Q1 2013).